Skip to main content
Figure 3 | Critical Care

Figure 3

From: Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice

Figure 3

Survival distribution function according to bleeding control. Full line: Patients with controlled bleeding. Dotted line: Patients with uncontrolled bleeding. X-axis: Days after prothrombin complex concentrate infusion. Y-axis: Survival distribution function. Estimated survival rates were 84.5% in patients with controlled bleeding and 49.0% in patients with uncontrolled bleeding (log-rank P < 0.0001).

Back to article page